Tae Heum "Ted" Jeong
Mr. Jeong is a Managing Partner with KSV Global Innovations, an innovative growth-focused capital fund he joined in March 2018. He has more than 20 years of experience as a venture capitalist and a financial executive. Prior to joining NeuroBo, from December 2002 to March 2018, Mr. Jeong served as Chief Financial Officer of Rexahn Pharmaceuticals, a NYSE-listed biotechnology company, where he had responsibility for forming strategic alliances and executing license deal in the U.S., Europe and Asia and during which time he completed equity financings totaling more than $150 million. Prior to that, from May 1997 to November 2002, Mr. Jeong was a Senior Investment Manager at Hyundai Venture Investment Corporation (HVIC), where he operated two of the first health care venture capital funds in Korea, with responsibility for more than 51 investments in health technology, information and communications technology and clean technology. While at HVIC, Mr. Jeong realized attractive returns from 31 portfolio companies via IPOs, secondary, sales and acquisitions.
Mr. Jeong earned a B.S. and M.S. in Chemistry from Pohang University of Science & Technology, an M.S. in Finance from Johns Hopkins University, and a Doctor of Management from the University of Maryland.